Abiopharma

NeuroPace Reports First Quarter 2025 Financial Results

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Iridex Reports First Quarter 2025 Financial Results

New Form 8-K - Kezar Life Sciences, Inc. Filed: 2025-05-13 AccNo: 0001645666-25-000026 Size: 202 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Semler Scientific, Inc. Filed: 2025-05-13 AccNo: 0001554859-25-000018 Size: 670 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - BIOADAPTIVES, INC. Filed: 2025-05-13 AccNo: 0001640334-25-000834 Size: 3 MB

New Form 144 - HCA Healthcare, Inc. Filed: 2025-05-13 AccNo: 0001965353-25-000082 Size: 4 KB

Sellas Life Sciences - SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update

New Form 8-K - MEI Pharma, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070298 Size: 581 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - CytomX Therapeutics, Inc. Filed: 2025-05-13 AccNo: 0001193125-25-118805 Size: 400 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - AN2 Therapeutics, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070305 Size: 308 KB Item 9.01: Financial Statements and Exhibits

New Form 4 - NEOGENOMICS INC Filed: 2025-05-13 AccNo: 0001077183-25-000104 Size: 32 KB

Savara Inc. - Savara Reports First Quarter 2025 Financial Results and Provides a Business Update

Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Spectral AI Announces 2025 First Quarter Financial Results